UHRF1 and cholangiocarcinoma: Although a few studies have suggested that UHRF1 overexpression may serve as an adverse prognostic factor in intrahepatic CCA, our analysis of the TCGA-CHOL cohort (approximately 40 cases) did not reveal a clear association between the expression levels of miR-1 or UHRF1 and patient survival (Figure S3) [36].